Who
Jeffrey Alan Wolf
Director
Company insider
Files Form 4 as: Director, Theriva Biologics; Chief Executive Officer, Scorpius Holdings.
In numbers
- Trades disclosed
- 57
- Buys
- 2
- Sells
- 0
- Bought
- $10K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 27 Feb 2007
- Last trade
- 5 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 6 Jan 2026 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 29 Apr 2025filed 1 May 2025 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | Scorpius Holdingsoption or derivative | SEC FORM 4 Code A | —2,500,000 | filing |
| 16 May 2024filed 17 May 2024 | Scorpius Holdings | SEC FORM 4 Code A | —2,500,000 | filing |
| 14 Dec 2023filed 15 Dec 2023 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 15 Dec 2022filed 16 Dec 2022 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | NightHawk Biosciencesoption or derivative | SEC FORM 4 Code A | —2,843,137 at $0.00 | filing |
| 30 Dec 2021filed 3 Jan 2022 | Heat Biologicsoption or derivative | SEC FORM 4 Code J | —231,987 at $0.00 | filing |
| 30 Dec 2021filed 3 Jan 2022 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —231,987 at $0.00 | filing |
| 23 Dec 2021filed 27 Dec 2021 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 13 Dec 2021filed 15 Dec 2021 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —393,761 at $0.00 | filing |
| 13 Dec 2021filed 15 Dec 2021 | Heat Biologics | SEC FORM 4 Code A | —246,305 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | Heat Biologics | SEC FORM 4 Code A | —288,100 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —147,980 at $0.00 | filing |
| 30 Dec 2020filed 31 Dec 2020 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 24 Aug 2020filed 25 Aug 2020 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —1,412,100 at $0.00 | filing |
| 28 Jul 2020filed 29 Jul 2020 | Heat Biologicsoption or derivative | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 2 Jan 2020filed 2 Jan 2020 | Heat Biologics | SEC FORM 4 Code A | —1,980,000 at $0.00 | filing |
| 31 Dec 2019filed 2 Jan 2020 | Heat Biologics | SEC FORM 4 Code A | —900,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.